Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Efficacy and Tolerability of Rimegepant for the Acute Treatment of Migraine in Adults Unsuitable for Triptan Use

ClinicalTrials.gov ID: NCT05509400

Public ClinicalTrials.gov record NCT05509400. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 9:32 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

BHV3000-406 (C4951004): A Phase 4, Randomized, Double-blind Placebo-Controlled, Efficacy and Tolerability Trial of Rimegepant for the Acute Treatment of Migraine in Adults Unsuitable for Triptan Use

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is being conducted to evaluate the efficacy and tolerability of rimegepant in a population of adults that are unsuitable for triptan medications due to a previous intolerance, lack of efficacy, or contraindication (including a history of clinically-relevant cardiovascular disease).

Study identification

NCT ID
NCT05509400
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Pfizer
Industry
Enrollment
813 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 18, 2022 (Actual)
Primary completion
Mar 10, 2025 (Actual)
Completion
Jun 10, 2025 (Actual)
Last update posted
Apr 21, 2026

2022 – 2025

United States locations

U.S. sites
23
U.S. states
14
U.S. cities
23
Facility City State ZIP Site status
Clinical Research Institute Los Angeles California 90048 —
Ki Health Partners LLC, dba New England Institute for Clinical Research Stamford Connecticut 06905 —
Wr-Msra, Llc Lake City Florida 32055 —
Sensible Healthcare LLC Ocoee Florida 34761 —
Sandhill Research, LLC d/b/a Accel Research Sites Network - Ormond Clinical Research Unit Ormond Beach Florida 32174 —
WR-Mount Vernon Clinical Research, LLC Sandy Springs Georgia 30328 —
Collective Medical Research Overland Park Kansas 66210 —
DelRicht Research New Orleans Louisiana 70115 —
Boston Clinical Trials Boston Massachusetts 02131 —
Community Clinical Research Network Inc Marlborough Massachusetts 01752 —
Michigan Headache & Neurological Institute Ann Arbor Michigan 48104 —
Rochester Medical Group Rochester Hills Michigan 48307 —
DM Clinical Research - Detroit Southfield Michigan 48076 —
Clinvest Research, LLC Springfield Missouri 65807 —
St Charles Clinical Research Weldon Spring Missouri 63304 —
DM Clinical Research - NY, NY Brooklyn New York 11220 —
New York Neurology Associates New York New York 10003 —
Montefiore Medical Center The Bronx New York 10461 —
Headache Wellness Center, PC Greensboro North Carolina 27405 —
Synexus Clinical Research US, Inc. - Anderson Anderson South Carolina 29621 —
Red Star Research, LLC Lake Jackson Texas 77566 —
DM Clinical Research Tomball Texas 77375 —
Northwest Clinical Research Center Bellevue Washington 98007 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 70 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05509400, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 21, 2026 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05509400 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →